top of page

IN THE NEWS

Latest Research

Welcome to our research news hub, where you can find current glioblastoma news, research, and trials, all curated by The Morizzo Foundation.

​

The Morizzo Foundation itself does not conduct research, however funds the doctors and researchers that do so.

Suppressing a Single Protein Sparks New Hope for Brain Cancer

Suppressing the ZNF638 protein triggers an antiviral immune response, making glioblastoma tumors more vulnerable to immune checkpoint inhibitors. This breakthrough in viral mimicry could pave the way for more effective immunotherapy treatments.

​

By The University of Miami Miller School of Medicine

March 17, 2025

supressing a single protien.png
ultra rapid.jpg

'Ultra-Rapid Testing Unlockes Cancer Genetics in the Operating Room

A groundbreaking ultra-rapid genetic test enables surgeons to detect and quantify cancer cells in just 15 minutes during brain surgery. This innovation could significantly improve tumor removal accuracy and patient outcomes.

​

Published by David March, NYU Langone Health

February 25, 2025

Glioblastoma Treated with Personalized Peptide Vaccine 

Personalized peptide vaccine targeting tumor-specific neoantigens significantly prolonged survival rates in patients with multiple vaccine-induced T-cell responses.​

​

By Latzer, et al. 

Published by Nature Communications

August 11, 2024

peptide molecule.jpg
glio cells.png

New Therapy for Glioblastoma Receives FDA Approval

Duke brain tumor researchers are part of earliest collaborations that led to the development drug, vorasidenib, shown to more than double progression-free survival.​

​

By Carol Harbers

Published by The Duke School of Medicine

August 06, 2024

Using AI, Researchers Pioneer a Potential New Immunotherapy Approach for Treating Glioblastoma 

USC researchers reprogramming cancer cells to convert them into dendritic cells, capable of identifying cancer cells.​

​

By Zara Abrams

Published by The Kelsey School of Medicine, USC

August 01, 2024

ai for immunotherapy.jpeg
phase II clinical trial thumbnail.jpg

Targeting Renin-Antiotensin System in Glioblastoma

Phase II Clinical Trial Using Suite of Repurposed Drugs to Target Renin-Angiotensin System in Glioblastoma​ Treatment

​​

By Julie McCrossin, A.M.

Published by Head and Neck Cancer Forum

June 18, 2024

Experimental mRNA Vaccine Hints at Potential Against Glioblastoma

Experimental mRNA vaccine loaded in nanoparticles shows promise in triggering immune response in early trials.​

​

By Carmen Phillips

Published by The National Cancer Institute

June 11, 2024

mrna for gbm.jpg
Cancer-cells-768x432.jpg

New Glioblastoma Treatment Reaches Helps Immune Cells Recognize Cancer Cells 

Skull-implantable ultrasound device enables targeted chemotherapy and immunotherapy delivery to glioblastoma, boosting immune response in early human trials.​​

​

By Marla Paul

Published by Feinberg School of Medicine, NU

June 06, 2024

New CAR-T Therapy Shows Promise for Glioblastoma 

CAR-TEAM Cells: A Dual-Targeting CAR-T Therapy Shows Early Promise in Reducing Glioblastoma Tumors in First-in-Human Trial​

​

By Brian Choi, M.D., Ph.D, et al.

Published by Massachusetts General Hospital

March 13, 2024

car-t therapy.jpg
Morizzo Foundation logo-alt_edited.png

The Morizzo Foundation is a 501(c)(3) nonprofit organization raising awareness of Glioblastoma, funding research efforts, and providing support to patients and their families in an effort to ensure equitable access to treatments.

​

© 2025 The Morizzo Foundation. All rights reserved. EIN: 99-208891

  • Instagram
  • Facebook
  • LinkedIn

Navigation

bottom of page